Neal Flomenberg's most recent trade in Tevogen Bio Holdings Inc. was a trade of 300,000 Common Stock done . Disclosure was reported to the exchange on June 27, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tevogen Bio Holdings Inc. | Neal Flomenberg | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2025 | 300,000 | 3,895,608 | - | 0 | Common Stock | |
| Tevogen Bio Holdings Inc. | Neal Flomenberg | See Remarks | Sale of securities on an exchange or to another person at price $ 1.09 per share. | 12 Mar 2025 | 232,968 | 3,595,608 | - | 1.1 | 253,935 | Common Stock |
| Tevogen Bio Holdings Inc. | Neal Flomenberg | See Remarks | Sale of securities on an exchange or to another person at price $ 1.14 per share. | 07 Mar 2025 | 71,273 | 3,969,212 | - | 1.1 | 81,251 | Common Stock |
| Tevogen Bio Holdings Inc. | Neal Flomenberg | See Remarks | Sale of securities on an exchange or to another person at price $ 1.09 per share. | 07 Mar 2025 | 70,384 | 3,898,828 | - | 1.1 | 76,719 | Common Stock |
| Tevogen Bio Holdings Inc. | Neal Flomenberg | See Remarks | Sale of securities on an exchange or to another person at price $ 1.05 per share. | 07 Mar 2025 | 70,252 | 3,828,576 | - | 1.1 | 73,765 | Common Stock |
| Tevogen Bio Holdings Inc. | Neal Flomenberg | See Remarks | Sale of securities on an exchange or to another person at price $ 1.21 per share. | 04 Mar 2025 | 110,659 | 4,129,004 | - | 1.2 | 133,897 | Common Stock |
| Tevogen Bio Holdings Inc. | Neal Flomenberg | See Remarks | Sale of securities on an exchange or to another person at price $ 1.10 per share. | 04 Mar 2025 | 88,519 | 4,040,485 | - | 1.1 | 97,371 | Common Stock |
| Tevogen Bio Holdings Inc. | Neal Flomenberg | See Remarks | Sale of securities on an exchange or to another person at price $ 1.28 per share. | 04 Mar 2025 | 14,639 | 4,239,663 | - | 1.3 | 18,738 | Common Stock |
| Tevogen Bio Holdings Inc. | Neal Flomenberg | See Remarks | Sale of securities on an exchange or to another person at price $ 1.62 per share. | 17 Oct 2024 | 1,078,600 | 4,254,302 | - | 1.6 | 1,747,332 | Common Stock |
| Tevogen Bio Holdings Inc. | Neal Flomenberg | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 5,332,902 | 5,332,902 | - | - | Common Stock |